PETER ROST: PHARMA MARKETING EXPERT WITNESS. AWP, MEDICAL DEVICE EXPERT.: Drug company mergers
screen2largeMM

Dr. Rost provides services as a pharmaceutical marketing expert witness. For more info see: Drug Expert Witness. Dr. Peter Rost email. Copyright © 2006-2013 InSync Communication. All rights reserved. Terms of use agreement, privacy policy and the computer fraud and abuse act.
.

PETER ROST: PHARMA MARKETING EXPERT WITNESS. AWP, MEDICAL DEVICE EXPERT.

Peter Rost, M.D., is a former Pfizer Marketing Vice President providing services as a medical device and drug expert witness and pharmaceutical marketing expert. Judge Sanders: "The court agrees with defendants' view that Dr. Rost is a very adept and seasoned expert witness." He is also the author of Emergency Surgery, The Whistleblower and Killer Drug. You can reach him on rostpeter (insert symbol) hotmail.com. Please read the terms of use agreement and privacy policy for this blog carefully.

Drug company mergers

This from Pharmalot:

In an attempt to take the guesswork out of such speculation, Catherine Arnold of Credit Suisse examines a host of issues confronting the 13 major drugmakers, and in an investor note this morning, decides that Wyeth and Bristol-Myers Squibb rate as the highest 'natural' targets, while Novartis and GlaxoSmithKline are the most likely acquirers.

The combinations deemed 'very' possible:

Pfizer + Wyeth;
Novartis + Wyeth;
Glaxo + Bristol;
Glaxo + Astra;
Sanofi + Bristol.

My comment: Verrrry interesting. Although, I have to admit, Wyeth has been to the altar a number of times and managed to get out of tying the not.

What wasn't mentioned above is that there are really only two drug companies that would make a good investment for the next ten years, based on pipeline and lack of patent expiration. And that is Wyeth and Novartis.

Perhaps another reason for the two to join in holy matrimony?


Best analysis, however, goes to WSJ, here is a graphic representation of the future of the drug industry, which I humbly think is not too far-fetched:


Labels: , ,

0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home